DAVITA INC. Restricted Cash and Cash Equivalents, Noncurrent
DAVITA INC. (DVA) had Restricted Cash and Cash Equivalents, Noncurrent of $1.27 billion as of 2012-09-30, per its 10-Q filed 2012-10-31.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2012-10-31
- 2012-09-30: Restricted Cash and Cash Equivalents, Noncurrent $1.27B.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2012-09-30 | $1.27B 10-Q · filed 2012-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |